Why TLSI fell on Nov 10
Down 12% on Nov 10, and still 28% under its Nov 9 close.
- It fell 12% on Nov 10, the day of its SEC filing (read the release).
−3Long-term trend
Down 12% on Nov 10, and still 28% under its Nov 9 close.
−3Long-term trend
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Holding it back | 35.8% more shares than a year ago |
| Latest filing | 10-Q, Nov 10 |
Tue Dec 1: Piper Sandler 38th Annual…Investor conference · date confirmed.
After its last 4 reports it closed -11.0% on average, higher 1 of 4 times.
TLSI is #80 of 86 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 80 |
Expected to report Thu Mar 4, before the open (in 103 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“The increase in revenue was primarily due to an increase in TriNav units sold.”
TLSI's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Revenue | $46M to $48M |
“The year-over-year increase in gross margin was primarily due to a reduction in cost per TriNav unit.”
From its results filing (SEC filing · Nov 10)
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 10, 2026 | -20.5% | -11.5% | -29.5% |
| Aug 6, 2026 | +1.4% | +15.2% | +15.6% |
| May 12, 2026 | -21.1% | -41.5% | -30.9% |
Sales grew every year from 2022 to 2025, to $45.2M. It lost money in each of the four years.
RSI 32.4, MACD below signal, below both averages. Not scored.
3 insiders bought $294K across 4 filings, and 3 insiders sold $5K across 4 filings, in the last 6 months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: TLSI is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.
“Our industry is highly competitive and subject to rapid and significant technological change as research provides a deeper understanding of the pathology of diseases and new technologies and treatments are developed.”
TLSI scores -5 today, which Breakaway calls Poor. It is #80 of 86 in Medical Devices by Quality Score, with 3 of 14 chart checks firing. Down 12% on Nov 10, and still 28% under its Nov 9 close. Shares: 35.8% more than a year ago (to Sep 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
TLSI scores -5 today, which Breakaway calls Poor (below zero). That is #80 of 86 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind TLSI's -5.
3 insiders bought $294K across 4 filings, and 3 insiders sold $5K across 4 filings, in the last 6 months. The newest is Mary T. Szela, CEO and President, who bought $89K on Nov 18. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.